Open Call for Pfizer Independent Medical Education Grant Request for Proposals 2026 United States of America (USA), This Request for Proposals (RFP) invites independent medical education initiatives designed to enhance knowledge and clinical practice related to adult Respiratory Syncytial Virus (RSV) immunization strategies. The funding opportunity places special emphasis on improving understanding of the relationship between RSV infection and its impact on cardiovascular and respiratory health outcomes among adults.
Although RSV is widely known for causing respiratory illness, growing evidence indicates that it can also contribute to serious cardiorespiratory complications, particularly among older adults and individuals with underlying health conditions. Despite these risks, awareness of RSV-related complications and the integration of preventive measures, including vaccination, into routine clinical care remain limited. Through this RFP, applicants are encouraged to develop educational programs that address knowledge gaps, promote evidence-based prevention strategies, and support healthcare professionals in incorporating RSV immunization into patient care practices for high-risk adult populations.
Applicants are encouraged to carefully review the full details and submit their grant applications before the specified deadline to seize this grant opportunity.
Last Date of Submission: 30th June 2026
Geographic Scope for Open Call for Pfizer Independent Medical Education Grant Request for Proposals 2026 United States of America (USA)
This funding opportunity is open to projects implemented within the United States. Proposed educational initiatives should focus on addressing the learning needs of healthcare professionals involved in adult vaccination and cardiovascular care across the country.
Project Types and Areas of Interest for Open Call for Pfizer Independent Medical Education Grant Request for Proposals 2026 United States of America (USA)
The RFP supports independent medical education projects that aim to strengthen healthcare professionals’ understanding of Respiratory Syncytial Virus (RSV) and its impact on adult health, particularly among individuals with cardiovascular disease. Proposed programs may seek to:
- Explain the epidemiology, disease burden, and cardiorespiratory consequences of RSV infection in adults.
- Increase awareness of the relationship between RSV and cardiovascular complications, including heart failure exacerbation, myocardial infarction, and arrhythmias.
- Review current recommendations and guidelines for adult RSV vaccination.
- Present emerging real-world evidence on the benefits of RSV prevention and its potential role in reducing cardiorespiratory hospitalizations.
- Support healthcare professionals in integrating RSV immunization discussions and preventive strategies into routine clinical practice.
Funding Information for Open Call for Pfizer Independent Medical Education Grant Request for Proposals 2026 United States of America (USA)
Applicants may request funding of up to USD 200,000 for individual projects. The total estimated funding available under this RFP is USD 200,000. Grant amounts may include direct project expenses, institutional overhead costs (subject to Pfizer’s policy cap of 28%), and other eligible indirect costs.
Eligibility Criteria for Open Call for Pfizer Independent Medical Education Grant Request for Proposals 2026 United States of America (USA)
Eligible Applicants
Applications may be submitted by organizations involved in healthcare education and professional development, including:
- Medical, dental, nursing, pharmacy, and allied health professional schools.
- Healthcare institutions and hospitals of any size.
- Professional associations and medical societies.
- Medical education companies.
- Other organizations whose mission supports healthcare professional education or healthcare improvement.
Additional Requirements
- Funding is available only to organizations, not to individuals or independent physician practice groups.
- For collaborative projects involving multiple institutions or departments, all participating organizations must have clearly defined roles, and the applicant organization must play a central leadership role.
- The applicant must be the project lead or an authorized representative acting on behalf of the project lead.
- The project lead must be employed by or contracted with the applicant organization.
- Applicant organizations must be legally eligible to receive grant funding directly from Pfizer.
- Organizations offering continuing medical education (CME) credits must hold the necessary accreditation.
Program Background
Respiratory Syncytial Virus (RSV) is a highly contagious respiratory virus and a leading cause of serious lower respiratory tract infections among older adults and individuals with underlying medical conditions. Patients with cardiovascular disease are particularly vulnerable, as RSV infection can worsen existing heart conditions and increase the risk of severe complications.
Since 2023, vaccines have been approved in the United States for the prevention of RSV-related lower respiratory tract disease. Current recommendations support vaccination for adults aged 75 years and older, as well as adults aged 50–74 years who are at increased risk of severe RSV illness. Emerging evidence also suggests that RSV vaccination may help reduce cardiorespiratory hospitalizations associated with RSV infection.
Despite these developments, awareness of RSV-related cardiovascular risks and adult vaccination recommendations remains limited among many clinicians who manage cardiovascular patients. This RFP seeks to address these educational gaps through high-quality, independent medical education initiatives.
Educational Topics of Interest
Projects should enhance healthcare professionals’ knowledge in areas such as:
- Epidemiology and clinical burden of RSV in adults.
- Impact of RSV on cardiovascular morbidity and mortality.
- Emerging evidence regarding RSV prevention and cardiorespiratory outcomes.
- Current adult RSV vaccination recommendations and guidelines.
- The role of cardiology professionals in identifying eligible patients, providing counseling, and supporting immunization efforts.
- Practical approaches for incorporating RSV prevention into cardiovascular disease management strategies.
Examples of Supported Educational Formats
Applicants may propose a variety of educational activities, including but not limited to:
- Educational sessions conducted during live cardiology conferences.
- Independent CME symposia and educational series held alongside major cardiology meetings.
- Peer-to-peer educational programs and discussion forums.
- Webinars, online courses, newsletters, and educational articles.
- Videos, podcasts, infographics, animations, and other digital learning resources.
- Enduring educational materials such as recorded sessions, toolkits, and downloadable resources connected to conference-based education.
Target Audience
The initiative is intended for healthcare professionals involved in cardiovascular care and adult immunization, including:
- Cardiologists across specialties such as general cardiology, heart failure, preventive cardiology, interventional cardiology, and electrophysiology.
- Cardiovascular nurse practitioners and physician assistants.
- Primary care physicians with a cardiovascular focus.
- Pharmacists and other healthcare professionals engaged in adult vaccination and cardiovascular disease management.
Funding Information
Applicants may request funding of up to USD 200,000 for individual projects under this grant opportunity. The total estimated budget available for this Request for Proposals (RFP) is USD 200,000.
The approved grant amount may cover direct project expenses, institutional overhead costs, and eligible indirect costs. Institutional overhead expenses are subject to a maximum limit of 28%, in accordance with Pfizer’s funding policy. Applicants should prepare realistic and well-justified budgets that align with the proposed project activities and objectives.
How to Submit:
IMPORTANT: Please read this section carefully since applications submitted not following these instructions will not be accepted and will be cancelled.
- Please go to http://www.cybergrants.com/pfizer/knowledgeand sign in.
- Note: there are individual portals for each grant application type. Please be sure to use the URL above.
- First-time users should click “Create your password”. It is strongly suggested to do this prior to the submission deadline.
- Click the “Start A New Knowledge Gap Application” button.
- Requirements for submission:
- Complete all required sections of the online application
- IMPORTANT: Upload proposal (see Appendix) in the General RFP Submission field.
- In the application:
- For the question “Competitive Grant?” select “Yes”
- Select the following Primary Area of Interest: VAV – RSV (Respiratory Syncytial Virus) – KG
- Select the following Competitive Grant Program Name: 2026 VAC US RSV Cardiovascular Care KG
Note: For more comprehensive details click the link below
Get full access to the grant information, visit the Official Website Link
No more Google search, join our Whats App Channel and get alerts as soon as we publish a post.
Hey, STEAL our Best Premium Content For Absolutely Free, Check Out the Links below
HOPE these will add value to your existing skills and knowledge
Our information bears no cost (it’s absolutely FREE), don’t let valuable information slip away.
Join our community of avid readers who are always in the know. Subscribe to our website; stay connected and engaged with the latest news, trends, and developments by subscribing today.
(PUSH the bell ICON)
Leverage the power of knowledge to propel your organization to new heights. Don’t miss out to explore our content
- Latest Funds for NGOs,
- NGO Jobs
- Resources (Helpful Guides and Courses)
- Premium Resources
- NGO related articles
Grants for NGOs, NGO Jobs, Resources, Nonprofit Fellowships Programs and Funds for NGOs – Empowering Your Mission
Sharing is Appreciated
